| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272562.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.043808082 |
Resistant |
| ENSG00000272562.1 |
Tanespimycin |
Brain lower grade glioma |
0.045290757 |
Resistant |
| ENSG00000272562.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.023041873 |
Resistant |